http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004050618-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3aa573ef60e8810f8c415d8f1db640c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9dc4307ebbe9c06f876022abcd46d39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_768774ae0240d8129ed280c8330bdcd8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-34
filingDate 2003-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46657a066bf68c30c94c7ccc37f3154d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a621b57f11bb437fa18c265fa2e3d7a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_588f310feaf7c8906264811fc789012d
publicationDate 2004-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004050618-A3
titleOfInvention Crystalline form f of atorvastatin hemi-calcium salt
abstract The present invention is directed to the novel polymorphic Form F of Atorvastatin calcium, processes for the preparation thereof and pharmaceutical compositions comprising this crystalline form.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100881103-B1
priorityDate 2002-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0241834-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03004470-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004022053-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0144181-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0144180-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03011826-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02057229-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02051804-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9703959-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0136384-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0243732-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070702-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9703958-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9851656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823

Total number of triples: 38.